Skip to main content
All lobbying filings

SPLITOAK STRATEGIES LLC

Lobbying for CARIS SCIENCE INC · Providing precision medicine services to patients battling aggressive cancers.

 Filing 3rd Quarter - Report
3rd Quarter (July 1 - Sep 30) 2025 · Texas · House · Senate · $40,000.00 income · posted Oct 20, 2025

Official filing document

 Bills named in this filing 1
 Lobbying activity 2
Medicare/Medicaid

Role of molecular profiling in cancer care; access to molecular profiling technologies and multi-cancer testing in Medicare; HR 5081, Telehealth Modernization Act, prior authorization reform in Medicare and appropriate reimbursement for cutting edge cancer diagnostic testing

Health Issues

Role of Artificial Intelligence and technology in cancer diagnostics and treatment; Value of precision medicine and blood-based diagnostic tools; Appropriate standards in oversight of lab-developed tests

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem